The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials

OBJECTIVE: To assess and compare the effectiveness of immune checkpoint inhibitors vs. chemotherapy for KRAS-mutant or EGFR-mutant non-small-cell lung cancers. METHODS: Until February 19, 2022, Cochrane Library, PubMed, Web of Science, and Embase were searched for relevant randomized controlled tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Li, Ling, Cheng, Sheng, Yu, Junxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439907/
https://www.ncbi.nlm.nih.gov/pubmed/36061356
http://dx.doi.org/10.1155/2022/2631852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439907/
https://www.ncbi.nlm.nih.gov/pubmed/36061356
http://dx.doi.org/10.1155/2022/2631852

Ejemplares similares